ASX:AYAHealth Care Equipment & ServicesHealth Care Technology
ARTRYA ORD
$2.680
$0.100 (3.60%)
Day Range
$2.650 - $2.870
52 Week Range
$0.560 - $5.240
Volume
494.48K
Avg Volume (10D)
428.40K
Market Cap
$423.67M
Price Chart
Market Statistics
Open$2.760
Previous Close$2.780
Day High$2.870
Day Low$2.650
52 Week High$5.240
52 Week Low$0.560
Valuation
Market Cap423.67M
Shares Outstanding158.08M
Price to Book4.74
Trading Activity
Volume494.48K
Value Traded1.36M
Bid$2.670 × 20,000
Ask$2.850 × 10,362
Performance
1 Day-3.60%
5 Day-16.25%
13 Week-32.32%
52 Week228.83%
YTD-43.10%
Technical Indicators
RSI (14)35.74
50-Day SMA$3.497
200-Day SMA$2.638
Latest News
Biotechnology
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease
Artrya (ASX: AYA) has signed a commercial agreement with US-based Northeast Georgia Health System for the use of its Salix AI cloud platform for point-of-care assessment and management of coronary artery disease.
1 min read
Biotechnology
Artrya Wins FDA Clearance to Advance Rollout of Salix Coronary Plaque Module
Artrya (ASX: AYA) has received clearance from the US Food and Drug Administration for its Salix Coronary Plaque module. The regulatory milestone enables the company to charge per-scan fees in its largest market, significantly enhancing revenue potential. The approval follows Artrya’s recent US launch and builds on momentum established with its Salix Coronary Anatomy platform. […]
3 min read
